/WPDPF

WPDPF Stock - WPD Pharmaceuticals Inc.

Q: What is the analyst price target for WPDPF?

Analyst price target information is not currently available for WPDPF.

Q: What is WPDPF's market cap?

Market capitalization information is not currently available for WPDPF.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for WPDPF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.04

52W High$0.03

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$-24,436	$-290,218	$-391,770	$-111.095
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-268,910	$-2,329,220	$-6,331,760	$-8,458,470	$-12,073,775
Net Income	$-80,082	$3.86M	$-5,623,150	$-7,522,701	$-12,776,341
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$0.03	$-0.05	$-0.07	$-0.18

Company Overview

WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company's drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Visit Website

Earnings History & Surprises

WPDPF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q2 2024

EPS Surprise History

Q1 24

No data

Q2 24

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2024	Jun 30, 2024	—	$-0.00	—	—
Q1 2024	Mar 31, 2024	—	$-0.00	—	—
Q1 2024	Jan 30, 2024	—	—	—	—
Q1 2023	Mar 13, 2023	—	—	—	—
Q4 2021	Nov 29, 2021	—	—	—	—

Frequently Asked Questions about WPDPF

What is WPDPF's current stock price?

WPD Pharmaceuticals Inc. (WPDPF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for WPDPF?

No analyst price targets are currently available for this stock.

What sector is WPD Pharmaceuticals Inc. in?

WPD Pharmaceuticals Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is WPDPF's market cap?

WPD Pharmaceuticals Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does WPDPF pay dividends?

No, WPD Pharmaceuticals Inc. does not currently pay a dividend to shareholders.